✦ LIBER ✦

Preliminary results of an ongoing phase I and pharmacokinetic study of CYC202, a novel oral cyclin-dependent kinases inhibitor, in patients with advanced malignancies

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I evaluation of seliciclib (R-rosc

✍ Christophe Le Tourneau; Sandrine Faivre; Valérie Laurence; Catherine Delbaldo; K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 378 KB

281 POSTER A phase I study of R547, a no

✍ D.R. Camidge; S.G. Eckhardt; A. Tan; G. Frenette; S. Diab; W. Depinto; J.F. Grip 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase I study of the safety, tolerabilit

✍ Glen J. Weiss, Manuel Hidalgo, Mitesh J. Borad, Daniel Laheru, Raoul Tibes, Rame 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 393 KB

Phase I and pharmacokinetic study of cap

✍ Maarten J. Deenen, Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Marie 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 299 KB

A phase I dose-escalation study of MSC19

✍ Graux, Carlos; Sonet, Anne; Maertens, Johan; Duyster, Justus; Greiner, Jochen; C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 526 KB

282 POSTER Preliminary results of a Phas

✍ P. Schöffski; H. Dumez; S.F. Jones; C. Fowst; P. Gerletti; H. Xu; J. Jakubczak; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB